13
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Membrane Estrogen Receptor Regulation of Hypothalamic Function

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Over the decades, our understanding of estrogen receptor (ER) function has evolved. Today we are confronted by at least two nuclear ERs, ERα and ERβ, and a number of putative membrane ERs, including ERα, ERβ, ER-X, GPR30 and Gq-mER. These receptors all bind estrogens or at least estrogenic compounds and activate intracellular signaling pathways. In some cases, a well-defined pharmacology and physiology has been discovered. In other cases, the identity or the function remains to be elucidated. This mini-review attempts to synthesize our understanding of 17β-estradiol membrane signaling within hypothalamic circuits involved in homeostatic functions, focusing on reproduction and energy balance.

          Related collections

          Most cited references66

          • Record: found
          • Abstract: not found
          • Article: not found

          Cloning of a novel receptor expressed in rat prostate and ovary.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Estrogen receptor pathways to AP-1.

            Estrogen receptor (ER) binds to estrogen response elements in target genes and recruits a coactivator complex of CBP-pl60 that mediates stimulation of transcription. ER also activates transcription at AP-1 sites that bind the Jun/Fos transcription factors, but not ER. We review the evidence regarding mechanisms whereby ER increases the activity of Jun/Fos and propose two pathways of ER action depending on the ER (alpha or beta) and on the ligand. We propose that estrogen-ERalpha complexes use their activation functions (AF-1 and AF-2) to bind to the p 160 component of the coactivator complex recruited by Jun/Fos and trigger the coactivator to a higher state of activity. We propose that selective estrogen receptor modulator (SERM) complexes with ERbeta and with truncated ERalpha derivatives use their DNA binding domain to titrate histone deacetylase (HDAC)-repressor complexes away from the Jun/Fos coactivator complex, thereby allowing unfettered activity of the coactivators. Finally, we consider the possible physiological significance of ER action at AP-1 sites.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Pomc-expressing progenitors give rise to antagonistic populations in hypothalamic feeding circuits

              Hypothalamic circuits regulating energy balance are highly plastic and develop in response to nutrient and hormonal cues. To identify processes that could be susceptible to gestational influences in the mouse, we characterized the ontogeny of proopiomelanocortin (POMC) and neuropeptide Y (NPY) populations, which exert opposing influences on food intake and body weight. These analyses revealed that Pomc is broadly expressed in immature hypothalamic neurons and that half of embryonic Pomc-expressing precursors subsequently adopt a non-POMC fate in the adult. Moreover, nearly one quarter of the mature orexigenic NPY population shares a common progenitor with anorexigenic POMC neurons. The rapid increase in the prevalence of childhood obesity and the concomitant rise in obesity-related medical morbidities and costs, lend urgency to the need for new insights into the causes and potential preventive measures for this disease 1. Mounting evidence supports the idea that the maternal environment can impart a lasting effect on susceptibility of offspring to obesity and type 2 diabetes2. The arcuate nucleus of the hypothalamus (ARH) is a critical component of the neuronal network regulating body weight, adiposity, and glucose homeostasis; and recent studies suggest that the development of arcuate neurons may be sensitive to maternal metabolic status 3. The discovery that ARH projections are influenced by leptin provided the first insight into potential mechanisms underlying “maternal programming” in the perinatal period 4. The gestational environment has also been shown to influence metabolic status of the offspring 5; however, little is known about the embryonic origins of arcuate lineages. The two best-characterized arcuate populations – orexigenic neurons co-expressing neuropeptide Y (NPY) and agouti-related protein (AgRP) and anorexigenic neurons expressing proopiomelanocortin (POMC) – produce antagonistic effects on food intake in response to nutrient and hormonal signals of peripheral energy status (reviewed in 6). Signals of positive energy balance, such as leptin and glucose, stimulate subsets of POMC neurons leading to decreased food intake, while inhibiting the release of orexigenic peptides from neighboring NPY neurons 7,8. NPY neurons are active when the energy supply is not sufficient to meet system demands, releasing AgRP and γ-Aminobutyric acid (GABA) to inhibit melanocortin-mediated suppression of food intake 7,9. Together, NPY and POMC neurons integrate signals of energy homeostasis to direct physiological processes that regulate body weight 10. We focused our initial efforts on characterizing the ontogeny of NPY and POMC neuronal lineages during gestation because nutrient and hormonal cues influence the formation of NPY and POMC circuits, consistent with the idea that these developmental processes influence metabolic phenotypes. Using the GenePaint digital mouse atlas, we found that Pomc and Npy are expressed at embryonic day 14.5 (E14.5), whereas only Pomc is expressed at E10.5 (www.genepaint.org). Given the earlier onset of Pomc expression, together with the established lateromedial gradient of hypothalamic neurogenesis 11, we predicted that the lateral POMC neurons would be born before the medial NPY neurons. To determine the birthdates of POMC and NPY neurons in the ARH, we injected dams with a single pulse of bromodeoxyuridine (BrdU) between E11.5–E16.5 and assessed the retention of the BrdU label by immunohistochemistry (IHC) at postnatal day 9 (P9). Unexpectedly, analysis of BrdU label in conjunction with Pomc or Npy expression, as assessed by fluorescent in situ hybridization (FISH) demonstrated that both populations are born between E11.5–12.5 (Fig. 1a–c). The peak birthdate of ARH neurons is E11.5–12.5 (Fig. 1a and 12); however, we observed that BrdU injections at E13.5 labeled some non-POMC, non-NPY cells in the lateral ARH (Supplementary Figs. 1 and 2). The shared birthdates of POMC and NPY neurons led us to consider whether these two antagonistic populations of neurons may be more closely related than expected. We characterized Pomc and Npy expression by two-color FISH across gestation (Fig. 1d–e). Pomc expression was first observed in the hypothalamic ventricular zone at E10.5–E11.5; from E12.5 expression was restricted to differentiated neurons, consistent with our birthdating studies. The number of Pomc-positive (Pomc +) cells reached a maximum at E13.5, after which its expression was extinguished in more than half of the population between E14.5 to 18.5 (Fig. 1f). Npy expression was not observed in the ventricular zone; it was first detected in laterally-situated cells in the rostralmost presumptive ARH at E13.5 and subsequently expanded to more medial and caudal regions. We did not detect appreciable levels of apoptotic cells by TUNEL stain, consistent with the idea that Pomc expression is turned off in a large percentage of immature hypothalamic neurons (data not shown and 13). These data argue that Pomc expression per se does not reflect the acquisition of a terminal cell fate; the gradual extinction of Pomc and progressive onset of Npy represent an ongoing maturation process that extends throughout gestation. Supporting this idea, POMC and NPY neurons do not acquire their terminal peptidergic phenotype, as reflected by Cart and Agrp expression, until the postnatal period in rodents 14,15. Pomc and Npy are expressed in mutually exclusive cell populations in adults 16, yet we detected Pomc + and Npy + co-localization at mid-gestation (Fig. 1e). To substantiate the unprecedented finding that a subset of neurons co-expresses Pomc and Npy, we compared the expression profiles of NPY neurons isolated from embryonic versus postnatal stages. We used fluorescence activated cell sorting (FACS) to collect GFP-positive (GFP+) cells from Npy-hrGFP embryos, which express GFP under the control of Npy promoter and enhancer elements17. We detected Pomc transcripts by PCR on sorted cells from E14.5, and not from P9 (Fig. 1g and Supplementary Fig. 4a,b). These observations support the idea that during gestation, a subset of Pomc-expressing cells can differentiate into NPY neurons. Next we used a genetic lineage tracing strategy 18 to visualize the mature POMC neuronal population, defined by Pomc expression in adults, in relation to the broad immature Pomc-expressing population in the embryo (Fig. 2). In Pomc-Cre;R26-GFP mice, Cre recombinase driven by Pomc regulatory elements directs the recombination of a floxed stop codon within the constitutively-active ROSA26 locus, permanently marking cells that expressed Pomc from gestation 19. To assess transcriptional activity in conjunction with a GFP reporter, we developed a technique to combine images of direct GFP fluorescence with FISH (Supplementary Figs. 3 and 5). When this assay was performed on adult tissue from Pomc-GFP transgenic animals, 95% of Pomc-GFP+ neurons co-express Pomc, validating the sensitivity of this technique (Fig. 2a) 7. In contrast, only half of the GFP+ cells in Pomc-Cre;R26-GFP mice express Pomc (Figs. 2b and Supplementary Fig. 6). Pomc-negative, GFP+ cells in Pomc-Cre;R26-GFP adults likely represent cells which turned off Pomc expression at some point after E13.5. GFP+ cell counts in Pomc-Cre;R26-GFP animals are consistently twice as high as those generated using Pomc FISH or direct fluorescence in Pomc-GFP animals (Fig. 2d). Based on our finding that Npy and Pomc are co-localized in a subset of embryonic neurons, we considered whether some of the Pomc-negative, GFP+ neurons in Pomc-Cre;R26-GFP adults are NPY neurons. Npy expression was detected in 17±2% of GFP+ neurons in adult Pomc-Cre;R26-GFP mice (herafter referred to as NPYP) (Fig. 2b). We used two strategies to independently verify this observation. First, confocal images of IHC on Npy-GFP;Pomc-Cre;R26-LacZ mice confirmed that 25% of NPY (GFP+) neurons co-express the Pomc-Cre lineage trace (β-Gal IHC) (Figs. 2c,e). Second, RT-PCR on FACS-purified GFP+ cells from Pomc-Cre;R26-GFP demonstrated that some cells marked by the lineage trace express Npy (Fig. 2f and Supplimentary Fig. 4c). These data provide evidence that NPYP neurons are derived from progenitors that are distinct from other ARH NPY neurons (NPYX), raising the possibility that they serve different functions within the hypothalamic feeding circuit, and thus may underlie the heterogeneous electrophysiological properties of NPY neurons 20. While the origins of NPY subpopulations may differ, their subsequent differentiation converges on an orexigenic, GABAergic phenotype, as we found that both NPYP and NPYX neurons express Agrp and Gad67 7. Our studies provide a framework to uncover the molecular mechanism underlying these differences within NPY neurons. In this study, we report that Pomc is expressed in the vast majority of neurons in the presumptive ARH (Fig. 1d,f). During gestation, Pomc transcription is extinguished in more than half of these cells, some of which subsequently differentiate into NPY neurons and some of which adopt alternative terminal fates. Consistent with our FISH analyses, when Pomc-Cre;R26-GFP mice were used to trace Pomc-derived lineages in the adult hypothalamus, we found that half of the GFP-labeled neurons are non-POMC neurons. Therefore, use of this Pomc-Cre driver to investigate the roles played by POMC neurons in circuits that regulate energy homeostasis would also affect a subset of NPY/AgRP neurons and others whose functions have yet to be determined. Unanticipated effects on antagonistic populations that also express the Cre transgene (i.e. NPY/AgRP) could ameliorate phenotypes resulting from genetic manipulations intended for POMC neurons. Moreover, some functions ascribed to POMC neurons could be mediated by non-POMC neurons that also express the Cre transgene. Classification of functionally distinct subsets of neurons derived from a Pomc + lineage is critical to elucidate how hormonal and nutrient signals are sensed by ARH neurons and relayed to downtream targets that regulate body weight and energy homeostasis. Supplementary Material 1 2
                Bookmark

                Author and article information

                Journal
                NEN
                Neuroendocrinology
                10.1159/issn.0028-3835
                Neuroendocrinology
                S. Karger AG
                978-3-318-02260-5
                978-3-318-02261-2
                0028-3835
                1423-0194
                2012
                September 2012
                25 April 2012
                : 96
                : 2
                : 103-110
                Affiliations
                aDepartment of Neurobiology, Brain Research Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, Calif., and bDepartment of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oreg., USA
                Author notes
                *Paul E. Micevych, PhD, Department of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1763 (USA), E-Mail pmicevych@mednet.ucla.edu
                Article
                338400 PMC3496782 Neuroendocrinology 2012;96:103–110
                10.1159/000338400
                PMC3496782
                22538318
                e7048884-726c-4e31-a3aa-a7993d040b7f
                © 2012 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 19 January 2012
                : 18 March 2012
                Page count
                Figures: 1, Pages: 8
                Categories
                Paper

                Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
                Estrogen receptor beta,17β-estradiol,Estrogen receptor alpha,GPR30 (GPER1),Gαq-coupled membrane estrogen receptor,mGluR1 receptor,Gonadotropin-releasing hormone neuron,Proopiomelanocortin neuron

                Comments

                Comment on this article